Linagliptin CAS: 668270-12-0 Hoton Mai Bayar da Kayayyaki

Linagliptin CAS: 668270-12-0 Mai Karu

Linagliptin (sunayen kasuwanci Tradjenta da Trajetna) shine mai hana dipeptidyl peptidase-4 (DPP-4) wanda FDA ta Amurka ta amince a watan Mayu 2011 don kula da nau'in ciwon sukari na 2 tare da abinci da motsa jiki.Linagliptin (BI-1356) an bayyana shi azaman babban zaɓi mai ƙarfi, ƙimar jinkirin da mai hana DPP-4 mai tsayi.Linagliptin ya taso ne daga ƙoƙarin ingantawa na masu hana DPP-4 na xanthine tare da jagorar farko da aka gano daga kamfen na HTS.

oda ko Neman Quote

Cikakken Bayani

Tags samfurin

Aikace-aikace da Tasiri

Linagliptin (TrajentaR, TradjentaTM, TrazentaTM, TrayentaTM) na baka ne, mai zaɓin zaɓi na dipeptidyl peptidase-4 kuma shine wakili na farko na ajin sa da aka kawar da shi ta hanyar da ba ta haihuwa.Ana nuna Linagliptin sau ɗaya kowace rana don kula da manya masu fama da ciwon sukari na 2. Linagliptin yana aiki don rage matakan glucose na jini ta hanyar hana enzyme DPP-4, don haka yana hana lalatawar incretin hormones (glucagon-like peptide-1) -1] da insulinotropic peptide mai dogaro da glucose) da rage tafiye-tafiyen tafiye-tafiyen glucose na postprandial.

Samfurin Samfura

Shirya samfur:

Ƙarin Bayani:

Abun ciki	Saukewa: C25H28N8O2
Assay	99%
Bayyanar	Farin foda
CAS No.	668270-12-0
Shiryawa	25KG
Rayuwar Rayuwa	shekaru 2
Adana	Ajiye a wuri mai sanyi da bushewa
Takaddun shaida	ISO.